Skip to content
Back to treatments
Transplant & Hematology~84% less than U.S.

Aplastic Anemia Treatment

再生障碍性贫血治疗

Duration
IST: 3-6 months to response; HSCT: 4-6 weeks inpatient
Recovery
IST: 3-6 months for blood count recovery; HSCT: 3-6 months for immune reconstitution
Average savings
84%
价格对比Price comparison

China versus the U.S.

China
$32,500
Range: $15,000–$50,000
United States
$200,000
Range: $100,000–$300,000
You save
84%
~$167,500 per procedure
China clinical rate
$15,000 – $50,000
$32,500
United States
$100,000 – $300,000
$200,000
You save
~84%
$167,500 per procedure

Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.

关于About this treatment

What the procedure involves.

Comprehensive aplastic anemia management including immunosuppressive therapy (ATG + cyclosporine + eltrombopag), supportive care, and allogeneic stem cell transplantation for severe cases. China's hematology centers have extensive experience treating aplastic anemia with both IST and transplant approaches, with particular expertise in haploidentical HSCT for patients lacking matched donors, offering cure rates of 80-90% in young patients.

流程Procedure steps

Step by step.

  1. 01

    Diagnostic Confirmation & Severity Grading

    Bone marrow biopsy with cellularity assessment, flow cytometry to exclude MDS/PNH, and genetic testing for inherited forms

    Duration · 3-5 days
  2. 02

    Treatment Strategy Decision

    Age-based algorithm: HSCT preferred for young patients with matched donor; IST for older patients or those without donors

    Duration · 1 week
  3. 03

    Treatment Delivery

    Horse ATG + cyclosporine + eltrombopag for IST pathway, or conditioning and allogeneic HSCT for transplant pathway

    Duration · IST: 5-day ATG course; HSCT: 4-6 weeks
  4. 04

    Response Monitoring & Supportive Care

    Regular blood counts, transfusion support, infection management, and assessment for clonal evolution

    Duration · 3-12 months
Benefits
  • High cure rates with HSCT in young patients (80-90%)
  • Haploidentical transplant option for patients without matched donors
  • Eltrombopag addition improves IST response rates to 80%+
  • Comprehensive supportive care and blood product availability
Considerations
  • ATG can cause severe allergic reactions and serum sickness
  • HSCT carries graft failure and GVHD risks
  • Clonal evolution to MDS or AML in 10-15% of IST patients
  • Prolonged immunosuppression increases infection vulnerability
下一步Next step

Ask the AI for hospitals that handle aplastic anemia treatment.

Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.